The high-flow oxygen therapy devices market revenue totaled US$ 1,494.8 million in 2023, according to Future Market Insights (FMI) study. The overall sales of high-flow oxygen therapy devices are expected to reach US$ 1,567.2 million by 2033, at a CAGR of 0.5% from 2023 to 2033.
With the growing incidence of acute respiratory failure in infected patients and the requirement for non-invasive respiratory support, sales are expected to improve over the forecast period. Demand for heated humidifiers is also projected to grow, accounting for more than 48.18% of high-flow oxygen therapy device sales in 2023.
| Attribute | Details |
|---|---|
| High-flow Oxygen Therapy Devices Market Size (2023) | US$ 1,494.8 million |
| High-flow Oxygen Therapy Devices Market Size (2033) | US$ 1,567.2 million |
| High-flow Oxygen Therapy Devices Market CAGR (2023 to 2033) | 0.5% |
| High-flow Oxygen Therapy Devices Market Size (2022) | US$ 1,805.1 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The rising prevalence of respiratory diseases, increasing community infections, and hospital-acquired infections are creating opportunities for high-flow nasal flow cannula products. Furthermore, growing investments by key players for the development of an advanced product that is easy to use and provides comfort to users are also expected to create growth opportunities shortly for the high-flow oxygen therapy devices market.
Demand for high-flow oxygen therapy in new pathogen outbreaks and high return on investment could be realized by increasing manufacturing capabilities in times of new pathogen/infection emergence providing opportunities for key players in the market.
Direct costs related to respiratory disease are higher, which requires a unified strategy that helps in real breathing help. The overall high cost associated with oxygen therapy, from hospitalization to post-discharge care, is expected to slow down the growth of the market. This hindrance is dominant in developing and emerging regions.
Principal Consultant
According to Future Market Insights (FMI), the sales of high-flow oxygen therapy devices are projected to expand at a 0.5% CAGR from 2023 to 2033. Going forward, the market is projected to be driven by the following factors:
The heightened cases of hospital-acquired respiratory infections led to market growth in the historical period, thus resulting in its high growth rate of 28.4% CAGR from 2018 to 2022. In December 2019, the COVID-19 pandemic engulfed the world. This highly transmissible respiratory disease significantly spiked the demand for medical masks, gloves, and other equipment like oxygen therapy devices.
The World Health Organization (WHO) recommended medical equipment and personal protection to contain the spread of the virus. Following the outbreak, governments across the globe increased manufacturing by 40% to meet the rising demand for medical equipment such as oxygen therapy devices. In 2022, the market stood at US$ 1,805.1 million.
Over the forecast period, the market is projected to witness a significant low in terms of CAGR. From 2023 to 2033, FMI has predicted a reduced CAGR of 0.5%, in contrast to the 28.4% CAGR witnessed during the historical period, especially during the pandemic.
The historical growth was run by manic purchases of high-flow oxygen therapy devices. The growth has subsided, as have the Covid-19 cases.
Other aspects acting as non-cooperative factors include the high cost of these devices. The initial investment needed to obtain these devices and the ongoing operational costs could cut short their adoption, particularly in resource-constrained healthcare settings.
Intense competition from low-cost alternatives like nasal cannulas and standard oxygen masks might hinder the adoption of high-flow oxygen devices.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country/Region | Market Share % (2022) |
|---|---|
| North America | 29.8% |
| The United States | 28.7% |
In 2023, the United States is estimated to account for over 96% value share in North America. Acute respiratory failure (ARF) is still a significant cause of morbidity and mortality among pediatric and adult demographics. The annual mortality rate is generally ranging between 50% and 70%, with the incidence in the United States as high as 150,000 cases.
The risk of ARF increases with age and is especially high among people aged 65 and above. Thus, the growing aging population with high incidences of respiratory diseases and the need for high-flow oxygen therapy is creating lucrative growth opportunities in North America, specifically in the United States.
| Country/Region | Market Share % (2022) |
|---|---|
| Europe | 16.6% |
| Germany | 4.5% |
Germany is anticipated to represent more than 24% of the Europe market in 2033. Continuous product development and new launches are boosting the market growth in the country. Also, the presence of companies such as Drägerwerk AG & Co. KGaA is supporting expansion in Germany.
Leading industry players are leveraging opportunities for technological developments to achieve product effectiveness and minimum complications. Manufacturers in Europe are focusing on aspects such as minimal surface contact friction of cannulation, optimum access, accurate delivery and positioning of the cannula, and physician's and patient convenience to increase the demand for high-flow oxygen therapy devices.
For example, in February 2019, Hamilton Medical AG launched a single-use nasal cannula- Nuflow, for high-flow oxygen therapy in neonates. The cannulas were made available in four sizes, including a pair of fixation patches and one adapter (OD 15 mm).
The Australia market is projected to exhibit an -5.7% CAGR from 2021 to 2025 and 1.8% from 2025 to 2033 throughout the forecast period. With increasing incidences of respiratory illness and growing adoption of high-flow oxygen therapy devices, i.e., around 4,394 heated humidifiers installed in the country in 2020, these factors are supplementing the market growth.
| Country | India |
|---|---|
| Value CAGR % (2023 to 2033) | -0.3% |
The India market is projected to account for more than 58% of the sales registered in South Asia in 2023. Various factors, such as increasing government spending, growing investment by leading players, and various government and non-government organizations' awareness programs, supplement market growth in the region.
| Country | China |
|---|---|
| Value CAGR % (2023 to 2033) | 0.8% |
The market for high-flow oxygen therapy devices in China is exhibiting a 0.8% CAGR and is expected to account for more than 36% of the East Asia market in 2033. The increasing prevalence of respiratory diseases, escalating geriatric population, and increasing adoption of high-flow oxygen therapy in a patient with acute respiratory failure (ARF), pneumonia, asthma, and interstitial lung disease are expected to surge demand for high-flow oxygen therapy devices in China.
| Segment | Heated Humidifiers Segment |
|---|---|
| Value Share % (2022) | 48.18% |
The heated humidifiers segment is projected to show steady growth, reflecting a high share of 48.18% in 2022. Increasing customer awareness about respiratory diseases such as asthma, sinusitis, and other allergies is driving the demand for heated humidifiers in the market.
| Segment | Acute Respiratory Failure |
|---|---|
| Value Share % (2022) | 90.46% |
The acute respiratory failure segment is projected to show steady growth in the forecast period with a CAGR of -3.1% accounting for a market share of 90.46% in 2022. The acute respiratory failure segment holds a higher share in the high-flow oxygen therapy devices market.
Pneumonia is expected to grow considerably throughout the forecast period as the pandemic improves.
Five hundred beds and above hospitals are leading the market; 500 beds and above hospitals have reflected significant growth with an -2.4% CAGR. The overburden of COVID-19 patients in large hospitals, which were primarily catering to the infected population, has primarily led to the dominance of this segment in the historical period. The segment is slowly losing its significance post the pandemic.
The leading key players rely on innovation and release new devices equipped with advanced technology to boost production efficiency. These companies are investing increasingly in research and development to maintain their competitive edge and status in the market. Developing new technologies and delivering them for the betterment of the patient's health is the key strategy adopted by most companies.
For instance, Armstrong Medical released the second generation FD140i in June 2020. The device is a better dual therapy flow driver with an easier changeover from CPAP to HFOT.
In 2020, Resmed launched the CPAP mask-Airlift f30i for hospitals and respiratory care physicians in the United States.
Key Players in the Market
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value. |
| Key Countries Covered | The United States, Canada, Germany, the United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, South Africa |
| Key Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | Draegerwerk AG & Co. KGaA; Teleflex Medical GmBH; Philips Respironics; Vapotherm, Inc.; ResMed; Vyaire Medical, Inc.; Fisher & Paykel Corporation Ltd.; Armstrong Medical; Flexicare Medical; Hamilton Medical Inc.; Intersurgical Inc.; Inspired Medical; WILAMed GmBH; Besmed Health Business Corp; Shenzhen Micomme Medical Technology Development Co. Ltd; Shenyang RMS Medical Tech Co. Ltd.; BMC Medical Co., Ltd. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The high-flow oxygen therapy devices industry is projected to reach a valuation of US$ 1,567.2 million by 2033.
Vapotherm, Inc. and ResMed are the top players in the high-flow oxygen therapy devices industry.
The United States is projected to hold a sizeable market share over the forecast period.
The high-flow oxygen therapy devices industry is projected to thrive at a CAGR of 0.5%.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. High Flow Nasal Cannulas
5.3.2. High Flow Oxygen Masks
5.3.3. Breathing Circuits
5.3.4. Heated Humidifiers
5.3.5. Accessories
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Pneumonia
6.3.2. Acute Respiratory Failure
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2023 to 2033
7.3.1. Less than 100 Beds Hospitals
7.3.2. 100-250 Beds Hospitals
7.3.3. 250-500 Beds Hospitals
7.3.4. 500 Beds and Above Hospitals
7.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Application
9.2.4. By End-User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End-User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Application
10.2.4. By End-User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End-User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product
11.2.3. By Application
11.2.4. By End-User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.3.4. By End-User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product
12.2.3. By Application
12.2.4. By End-User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.3.4. By End-User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product
13.2.3. By Application
13.2.4. By End-User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.3.4. By End-User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product
14.2.3. By Application
14.2.4. By End-User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Application
14.3.4. By End-User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Application
15.2.4. By End-User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Application
15.3.4. By End-User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Application
16.1.2.3. By End-User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Application
16.2.2.3. By End-User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Application
16.3.2.3. By End-User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Application
16.4.2.3. By End-User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Application
16.5.2.3. By End-User
16.6. U.K.
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Application
16.6.2.3. By End-User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Application
16.7.2.3. By End-User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Application
16.8.2.3. By End-User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Application
16.9.2.3. By End-User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Application
16.10.2.3. By End-User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Application
16.11.2.3. By End-User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Application
16.12.2.3. By End-User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Application
16.13.2.3. By End-User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Application
16.14.2.3. By End-User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product
16.15.2.2. By Application
16.15.2.3. By End-User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product
16.16.2.2. By Application
16.16.2.3. By End-User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product
16.17.2.2. By Application
16.17.2.3. By End-User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product
16.18.2.2. By Application
16.18.2.3. By End-User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product
16.19.2.2. By Application
16.19.2.3. By End-User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product
16.20.2.2. By Application
16.20.2.3. By End-User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product
16.21.2.2. By Application
16.21.2.3. By End-User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product
16.22.2.2. By Application
16.22.2.3. By End-User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product
16.23.2.2. By Application
16.23.2.3. By End-User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Application
17.3.4. By End-User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Draegerwerk AG & Co. KGaA
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Teleflex Medical GmBH
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Philips Respironics
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Vapotherm, Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. ResMed
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Vyaire Medical, Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Fisher & Paykel Corporation Ltd.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Armstrong Medical
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Flexicare Medical
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Hamilton Medical Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. Intersurgical Inc.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
18.1.12. Inspired Medical
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.12.5.2. Product Strategy
18.1.12.5.3. Channel Strategy
18.1.13. WILAMed GmBH
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.13.5.2. Product Strategy
18.1.13.5.3. Channel Strategy
18.1.14. Besmed Health Business Corp
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.14.5.2. Product Strategy
18.1.14.5.3. Channel Strategy
18.1.15. Shenzhen Micomme Medical Technology Development Co. Ltd
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
18.1.15.5.2. Product Strategy
18.1.15.5.3. Channel Strategy
18.1.16. Shenyang RMS Medical Tech Co. Ltd.
18.1.16.1. Overview
18.1.16.2. Product Portfolio
18.1.16.3. Profitability by Market Segments
18.1.16.4. Sales Footprint
18.1.16.5. Strategy Overview
18.1.16.5.1. Marketing Strategy
18.1.16.5.2. Product Strategy
18.1.16.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
High-flow Oxygen Therapy Devices Market
